Science
GLP-1 Weight Loss Drugs Linked to 30% Lower Breast Cancer Risk
A large study of women undergoing breast imaging suggests that GLP-1 medications may reduce the likelihood of developing breast cancer.
Topic
A large study of women undergoing breast imaging suggests that GLP-1 medications may reduce the likelihood of developing breast cancer.
Researchers used artificial intelligence to scan social media data, uncovering unreported symptoms associated with popular weight-loss drugs like Ozempic and Wegovy.